Steven Senne/Related Press
FILE – A health care provider masses a dose of Pfizer COVID-19 vaccine right into a syringe, Thursday, Dec. 2, 2021, at a cellular vaccination clinic in Worcester, Mass. In January 2022, an influential authorities advisory panel is contemplating COVID-19 boosters for youthful teenagers, because the U.S. battles the omicron surge and faculties wrestle with how one can restart lessons amid the spike. (AP Picture/Steven Senne, File)
“They mentioned it might be simple so simply do it already.”
— Michael Lin, Stanford College affiliate professor of neurobiology and bioengineering, in a Twitter submit urging drug firms to replace their COVID-19 vaccines for the now-dominant omicron variant. Pfizer and Moderna have since begun trials for an omicron-specific vaccine.